ID: ALA3981052

Max Phase: Preclinical

Molecular Formula: C31H38N6O6S

Molecular Weight: 622.75

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  Cc1ccc(S(=O)(=O)N2CCC[C@H]2C(=O)N[C@@H](Cc2ccc(NC(=O)CCCCNC(=N)N)cc2)C(=O)O)c2ccccc12

Standard InChI:  InChI=1S/C31H38N6O6S/c1-20-11-16-27(24-8-3-2-7-23(20)24)44(42,43)37-18-6-9-26(37)29(39)36-25(30(40)41)19-21-12-14-22(15-13-21)35-28(38)10-4-5-17-34-31(32)33/h2-3,7-8,11-16,25-26H,4-6,9-10,17-19H2,1H3,(H,35,38)(H,36,39)(H,40,41)(H4,32,33,34)/t25-,26-/m0/s1

Standard InChI Key:  OSUIXCNIVHYKRR-UIOOFZCWSA-N

Associated Targets(Human)

Integrin alpha-V/beta-1 222 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 622.75Molecular Weight (Monoisotopic): 622.2574AlogP: 2.71#Rotatable Bonds: 13
Polar Surface Area: 194.78Molecular Species: ZWITTERIONHBA: 6HBD: 6
#RO5 Violations: 2HBA (Lipinski): 12HBD (Lipinski): 7#RO5 Violations (Lipinski): 3
CX Acidic pKa: 3.33CX Basic pKa: 12.06CX LogP: 1.05CX LogD: 1.05
Aromatic Rings: 3Heavy Atoms: 44QED Weighted: 0.10Np Likeness Score: -0.85

References

1. Reed NI, Tang YZ, McIntosh J, Wu Y, Molnar KS, Civitavecchia A, Sheppard D, DeGrado WF, Jo H..  (2016)  Exploring N-Arylsulfonyl-l-proline Scaffold as a Platform for Potent and Selective αvβ1 Integrin Inhibitors.,  (10): [PMID:27774126] [10.1021/acsmedchemlett.6b00196]

Source